Science Explorer Back to mapMap
Discussion
Company · Edmonton · Canada

Seagen (Canada)

seagen.comROR OpenAlex
Research works
15
▲ 277% vs 2018-21
Citations
1.4k
89.9 per fractional work
Top-10% rate
8.5%
all institutions 10.0%
Open access
42%
world 40%
International
52%
world 18%
Seagen (Canada)

Not ranked overall: Seagen (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Seagen (Canada) work in?

In all years, 62% of research at Seagen (Canada) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (20%), Health Professions (7%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 62.3% of its workMedicine: 8 fractional works · 55.1% of its workOncology: 1 fractional works · 9.4% of its workHematology: 1 fractional works · 6.1% of its workPulmonary and Respiratory Medicine: 1 fractional works · 5.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.6% of its workPathology and Forensic Medicine: 1 fractional works · 4.0% of its workSurgery: 0 fractional works · 2.9% of its workDermatology: 0 fractional works · 2.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.2% of its workGeriatrics and Gerontology: 0 fractional works · 2.2% of its workInfectious Diseases: 0 fractional works · 2.2% of its workGenetics: 0 fractional works · 1.8% of its workEmergency Medicine: 0 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.4% of its workEpidemiology: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 6.5% of its workOccupational Therapy: 0 fractional works · 3.3% of its workGeneral Health Professions: 0 fractional works · 2.2% of its workRadiological and Ultrasound Technology: 0 fractional works · 1.1% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workLife Sciences: 5 fractional works · 31.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 20.3% of its workGenetics: 1 fractional works · 5.9% of its workMolecular Biology: 1 fractional works · 5.6% of its workCancer Research: 1 fractional works · 4.6% of its workClinical Biochemistry: 0 fractional works · 1.4% of its workCell Biology: 0 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 0.9% of its workEndocrinology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 5.5% of its workImmunology: 1 fractional works · 3.7% of its workVirology: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 3.8% of its workPlant Science: 0 fractional works · 2.7% of its workAgronomy and Crop Science: 0 fractional works · 1.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.2% of its workPharmacology: 0 fractional works · 2.2% of its workPhysical Sciences: 1 fractional works · 3.7% of its workChemical Engineering: 0 fractional works · 1.1% of its workChemical Health and Safety: 0 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 1.1% of its workMaterials Chemistry: 0 fractional works · 1.1% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.7% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 2.3% of its workSocial Sciences: 0 fractional works · 1.6% of its workCommunication: 0 fractional works · 1.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workALL ITS WORKSeagen (Canada)15fractional works, all years
Life Sciences32%Physical Sciences4%Health Sciences62%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine855.1%
    2. Health Professions16.5%
    3. Nursing00.7%
    1. Biochemistry, Genetics and Molecular Biology320.3%
    2. Immunology and Microbiology15.5%
    3. Agricultural and Biological Sciences13.8%
    4. Pharmacology, Toxicology and Pharmaceutics02.2%
    1. Chemical Engineering01.1%
    2. Materials Science01.1%
    3. Environmental Science00.7%
    4. Computer Science00.3%
    5. Mathematics00.3%
    6. Engineering00.1%
    1. Social Sciences01.6%
    2. Economics, Econometrics and Finance00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.05× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.83× its world share, 0 worksImmunology and Micro…Computer Science: 0.20× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringMathematics: 1.33× its world share, 0 worksMathematicsMedicine: 4.04× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.46× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.65× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Medicine4.04×2 works
  2. Immunology and Microbiology1.83×0 works
  3. Economics, Econometrics and Finance1.46×0 works
  4. Mathematics1.33×0 works
  5. Biochemistry, Genetics and Molecular Biology1.05×0 works
  6. Social Sciences0.65×0 works
  7. Computer Science0.20×0 works
  8. Engineering0.03×0 works

What are the most cited papers from Seagen (Canada)?

The most cited paper from Seagen (Canada) is "Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study" (Barbara Pro, Ranjana H. Advani, Pauline Brice et al., 2012), with 1,001 citations. Next come "Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (785) and "Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels" (569).

Most cited papers
#PaperReleasedCitations
1 Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology Open access 21 May 2012 1,001
2 Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Laurie Helen Sehn, Alex Francisco Herrera, Christopher R. Flowers et al. · Journal of Clinical Oncology Open access 6 Nov 2019 785
3 Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels James N. Kochenderfer et al. · Journal of Clinical Oncology Open access 14 Mar 2017 569
4 Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Christopher James Gibson et al. · Journal of Clinical Oncology Open access 23 Feb 2017 483
5 The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir Stephen C. Piscitelli, Aaron H. Burstein, Nada Welden et al. · Clinical Infectious Diseases 15 Jan 2002 432
All 49 most cited papers, with filters and sorting

Which research topics does Seagen (Canada) publish most on?

By volume in 2022-now: HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Bladder and Urothelial Cancer Treatments and Renal cell carcinoma treatment.

HER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksBladder and Urothelial C…0Bladder and Urothelial Cancer Treatments: 0 fractional worksRenal cell carcinoma tre…0Renal cell carcinoma treatment: 0 fractional worksCommunication and COVID-…0Communication and COVID-19 Impact: 0 fractional worksJournalism and Media Studies: 0 fractional worksAdvertising and Communication Studies: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksUrinary and Genital Oncology Studies: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingSurgeryPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Bladder and Urothelial Cancer Treatments Surgery 0 works
  4. 4 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  5. 5 Communication and COVID-19 Impact Communication 0 works
  6. 6 Journalism and Media Studies Communication 0 works
  7. 7 Advertising and Communication Studies Communication 0 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 0 works
  9. 9 Urinary and Genital Oncology Studies Surgery 0 works
  10. 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.9%not open58.1%

World: 40% of research is openly available.

with international co-authors52.3%domestic only47.7%

World: 18% is written across borders.

How has Seagen (Canada)'s research output changed?

Output in 2022-2025 was 277% higher than in 2018-2021.

1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Seagen (Canada) as a percentage of every work published that year, 0.000022% in 2023.

0.00020%0.00040%Seagen (Canada)0.000022% in 202419801990200020102020

Fractional works of Seagen (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Edmonton

All research institutions in Edmonton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Seagen (Canada). Posts are plain text and can be reported.